The EU paediatric regulation:. Effects on paediatric psychopharmacology in Europe

European Neuropsychopharmacology

Volumn 21, Issue 8, 2011, Pages 565-570

  Stoyanova Beninska, Violeta V ^a   Wohlfarth, Tamar ^a   Isaac, Maria ^b,c   Kalverdijk, Luuk J ^d   van den Berg, Henk ^a,e   Gispen de Wied, Christine ^a,f  

^a MEDICINES EVALUATION BOARD   (Netherlands)

^b EUROPEAN MEDICINES AGENCY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e EMMA CHILDREN S HOSPITAL   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Adolescents; Antidepressants; Antipsychotics; Children; Psychopharmacology; Safety

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATOMOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT DISEASE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD PSYCHIATRY; CHILDHOOD DISEASE; CLINICAL PRACTICE; DEPRESSION; DRUG INDICATION; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG RESEARCH; EUROPE; HUMAN; MAJOR DEPRESSION; MEDICAL CARE; OBSESSIVE COMPULSIVE DISORDER; PARAMEDICAL PERSONNEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA;

ADOLESCENT; ADOLESCENT PSYCHIATRY; CHILD; CHILD PSYCHIATRY; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DRUG INDUSTRY; EUROPEAN UNION; HUMANS; INFANT; INFANT, NEWBORN; PROFESSIONAL PRACTICE; PSYCHOPHARMACOLOGY;

EID: 79959912527     PISSN: 0924977X     EISSN: 0924977X     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.06.011     Document Type: Review

References (30)

1. Arnold L.E., Vitiello B., McDougle C., Scahill L., Shah B., Gonzalez N.M., Chuang S., Davies M., Hollway J., Aman M.G., Cronin P., Koenig K., Kohn A.E., McMahon D.J., Tierney E. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry 2003, 42(12):1443-1450.
2. Ban T.A. Pharmacotherapy of mental illness-a historical analysis. Progress in Neuropsychopharmacology & Biological Psychiatry 2001, 25(4):709-727.
3. Bobes J., Arango C., Garcia-Garcia M., Rejas J., CLAMORS Study Collaborative Group Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. The Journal of Clinical Psychiatry 2010, 3:280-286. Mar 7.
4. Brainstorming sessions 17th ECNP Congress, 2004. Co-opertation FDA EU about pediatric regulation: http://www.fda.gov/InternationalPrograms/FDABeyondOurBordersForeignOffices/EuropeanUnion/EuropeanUnion/EuropeanCommission/ucm114342.htm.
5. Gould M.S., Walsh B.T., Munfakh J.L., Kleinman M., Duan N., Olfson M., Greenhill L., Cooper T. Sudden death and use of stimulant medications in youths. The American Journal of Psychiatry 2009, 166(9):992-1001.
6. Hetrick S., Merry S., McKenzie J., Sindahl P., Proctor M. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents 2007, Cochrane Database Syst Rev, Jul 18, 3, CD004851. http://www.dsm5.org/ProposedRevisions/Pages/InfancyChildhoodAdolescence.aspx http://www.ema.europa.eu/htms/human/paediatrics/introduction.htm http://www.ema.europa.eu/pdfs/human/paediatrics/24883409en.pdf http://www.ema.europa.eu/htms/human/paediatrics/decisions.htm.
7. Jadad A.R., Booker L., Gauld M., Kakuma R., Boyle M., Cunningham C.E., Kim M., Schachar R. The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses. Canadian Journal of Psychiatry Revue Canadienne De Psychiatrie 1999, 44(10):1025-1035.
8. Kalverdijk L.J., Tobi H., van den Berg P.B., Buiskool J., Wagenaar L., Minderaa R.B., de Jong-van den Berg L.T. Use of antipsychotic drugs among Dutch youths between 1997 and 2005. Psychiatric Services 2008, 59:554-560.
9. Koelch M., Schnoor K., Fegert J.M. Ethical issues in psychopharmacology of children and adolescents. Current Opinion in Psychiatry 2008, 21(6):598-605.
10. Libby A.M., Brent D.A., Morrato E.H., Orton H.D., Allen R., Valuck R.J. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. The American Journal of Psychiatry 2007, 164:884-891.
11. McCunne S., Mathis L., Cochetto D., Ball S., Rodriguez W. More appropriate clinical trial design for drug labels. Drug Information Journal 2006, 40:185-195.
12. Moreno C., Laje G., Blanco C., Jiang H., Schmidt A.B., Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry 2007, 64:1032-1039.
13. Murray M.L., Wong I.C., de Vries C.S. Treating major depression in children and adolescents: research is needed into safer and more effective drugs. BMJ 2004, 328(7438):524-525.
14. Murray M.L., Wong I.C., Thompson M. Do selective serotonin reuptake inhibitors cause suicide? Antidepressant prescribing to children and adolescents by GPs has fallen since CSM advice. BMJ 2005, 330(7500):1151. May 14.
15. Musto D.F. Prevailing and shifting paradigms: a historical perspective. Lewis's Child and Adolescent Psychiatry. A Comprehensive Textbook 2007, Lippincott, Williams and Wilkins, Philadelphia. 4th edition. A. Martin, F.R. Volkmar, M. Lewis (Eds.).
16. Pediatric Labeling Changes through February 24, 2010. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm.
17. Rapado-Castro M., Soutullo C., Fraguas D., Arango C., Payá B., Castro-Fornieles J., González-Pinto A., Parellada M., Graell M., Baeza I., Bombin I. Predominance of symptoms over time in early-onset psychosis: a principal component factor analysis of the Positive and Negative Syndrome Scale. The Journal of Clinical Psychiatry 2010, 71(3):327-337. Mar.
18. Rice, C. Prevalence of Autism Spectrum Disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. 2009, Surveillance Summaries December 18, 2009 / 58(SS10),1-20.
19. Saint-Raymond A., Seigneuret N. The European paediatric initiative: 1 year of experience. Paediatric Drugs 2009, 11(1):9-10.
20. Schirm E., Tobi H., Zito J.M., de Jong-van den Berg L.T. Psychotropic medication in children: a study from the Netherlands. Pediatrics 2001, 108:E25.
21. Tobi H., Scheers T., Netjes K.A., Mulder E.J., de Bildt A., Minderaa R.B. Drug utilisation by children and adolescents with mental retardation: a population study. European Journal of Clinical Pharmacology 2005, 61(4):297-302.
22. Vitiello B. Pharmacoepidemiology and pediatric psychopharmacology research. Journal of Child and Adolescent Psychopharmacology 2005, 15:10-11.
23. Vitiello B. Recent developments and strategies in pediatric pharmacology research in the USA. The Child 2008, 2:36.
24. Vitiello B., Correll C., van Zwieten-Boot B., Zuddas A., Parellada M., Arango C. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. European Neuropsychopharmacology 2009, 19(9):629-635. Sep.
25. Walkup J.T., Cruz K., Kane S., Geller B. The future of pediatric psychopharmacology. Clinics of North America 1998, 45(5):1265-1278. Oct.
26. Weissman M.M., Klerman G.L. Depression: current understanding and changing trends. Annual Review of Public Health 1992, 13:319-339.
27. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E., 2004. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. Apr 24, 363,9418,1341-5.
28. Wohlfarth T., van Zwieten B.J., Lekkerkerker F.J., Gispen-de Wied C.C., Ruis J.R., Elferink A.J., Storosum J.G. Antidepressants use in children and adolescents and the risk of suicide. European Neuropsychopharmacology 2006, 16:79-154.
29. Wohlfarth T., Kalverdijk L., Rademaker C., Schothorst P., Minderaa R., Gispen-de Wied C. Psychopharmacology for children: from off label use to registration. European Neuropsychopharmacology 2009, 19:603-608. 10.1016/j.euroneuro.2009.04.007.
30. Zito J.M., Safer D.J., Dosreis S., Gardner J.F., Boles M., Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA: The Journal of the Amelrican Medical Association 2000, 283(8):1025-1030.